These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32089351)

  • 1. The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
    Ohashi T; Terasawa K; Aoki M; Akazawa T; Shibata H; Kuze B; Asano T; Kato H; Miyazaki T; Matsuo M; Inoue N; Ito Y
    Auris Nasus Larynx; 2020 Aug; 47(4):658-667. PubMed ID: 32089351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma.
    Meyer HJ; Purz S; Sabri O; Surov A
    PLoS One; 2018; 13(9):e0202897. PubMed ID: 30188926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of
    Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
    Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.
    Bojaxhiu B; Sinovcic D; Elicin O; Templeton AJ; Shelan M; Wartenberg J; Alberts I; Rominger A; Aebersold DM; Zaugg K
    Radiat Oncol; 2022 Aug; 17(1):141. PubMed ID: 35964056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
    Creff G; Devillers A; Depeursinge A; Palard-Novello X; Acosta O; Jegoux F; Castelli J
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):471-479. PubMed ID: 32215611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between [
    Surov A; Meyer HJ; Höhn AK; Winter K; Sabri O; Purz S
    Mol Imaging Biol; 2019 Apr; 21(2):368-374. PubMed ID: 29931433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
    Gupta T; Chatterjee A; Rangarajan V; Purandare N; Arya S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
    Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):162-170. PubMed ID: 31496204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of volumetric 4'-[methyl-
    Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y
    Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2-like macrophage polarization in high lactic acid-producing head and neck cancer.
    Ohashi T; Aoki M; Tomita H; Akazawa T; Sato K; Kuze B; Mizuta K; Hara A; Nagaoka H; Inoue N; Ito Y
    Cancer Sci; 2017 Jun; 108(6):1128-1134. PubMed ID: 28370718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune microenvironment of the gene signature reflecting the standardised uptake value on
    Han S; Oh JS; Kim JS
    Ann Nucl Med; 2021 Jan; 35(1):65-75. PubMed ID: 33044632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
    Guezennec C; Robin P; Orlhac F; Bourhis D; Delcroix O; Gobel Y; Rousset J; Schick U; Salaün PY; Abgral R
    Head Neck; 2019 Feb; 41(2):495-502. PubMed ID: 30549149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
    Ito K; Yokoyama J; Miyata Y; Toyohara J; Okasaki M; Minamimoto R; Morooka M; Ishiwata K; Kubota K
    Nucl Med Commun; 2015 Mar; 36(3):219-25. PubMed ID: 25369751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Significance of Tumor SUVmax Value in Pre- and Post-Chemoradiotherapy 18F-FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma.
    Kandemir O; Demir F; Avcı GG
    Niger J Clin Pract; 2024 Jun; 27(6):748-753. PubMed ID: 38943299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of
    Mayoral M; Paredes P; Saco A; Fusté P; Perlaza P; Tapias A; Fernandez-Martinez A; Vidal L; Ordi J; Pavia J; Martinez-Roman S; Lomeña F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):80-86. PubMed ID: 28869177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.